# Benjamin - VZP Navigator Feature (Screen Plan)

**Feature Type:** Inline enhancement pro Chat Interface

**Platform:** Web (Modal 1200Ã—800px) + Chrome Extension (800Ã—600px)

**Priority:** ğŸ”¥ MUST HAVE (FÃ¡ze 2)

**User Problem:** LÃ©kaÅ™i musÃ­ ruÄnÄ› kontrolovat VZP web pro ovÄ›Å™enÃ­ hrazenÃ­ lÃ©kÅ¯, coÅ¾ zabÃ­rÃ¡ 5+ minut a pÅ™eruÅ¡uje workflow.

---

## Feature Overview

VZP Navigator je **MCP tool integrace**, kterÃ¡ automaticky zobrazuje VZP ÃºhradovÃ© informace pÅ™Ã­mo v Benjamin Chat odpovÄ›dÃ­ch, kdyÅ¾ lÃ©kaÅ™ klade dotazy tÃ½kajÃ­cÃ­ se lÃ©kÅ¯. Feature se vykresluje jako **inline enriched content** v existujÃ­cÃ­m Chat UI, nikoliv jako samostatnÃ¡ strÃ¡nka.

### KlÃ­ÄovÃ© Principy
- **Zero friction:** Data VZP se zobrazujÃ­ automaticky bez potÅ™eby explicitnÃ­ho "VZP mode"
- **Contextual awareness:** AI detekuje, kdy je ÃºhradovÃ¡ informace relevantnÃ­
- **Trust through transparency:** VÅ¾dy zobrazit zdroj dat (datum aktualizace VZP databÃ¡ze)
- **Actionable:** UmoÅ¾nit pÅ™Ã­mÃ© follow-up akce (Å¾Ã¡dost o IU, cenovÃ© srovnÃ¡nÃ­)

---

## Design Integration do ExistujÃ­cÃ­ho Chat UI

### Trigger ScÃ©nÃ¡Å™e

VZP Navigator se aktivuje, kdyÅ¾ lÃ©kaÅ™:
1. PÅ™Ã­mo se ptÃ¡ na hrazenÃ­: *"Je empagliflozin hrazenÃ½ VZP?"*
2. PtÃ¡ se na doporuÄenÃ­ lÃ©ku: *"JakÃ½ SGLT2 inhibitor pro diabetes?"* â†’ AI zmÃ­nÃ­ lÃ©k â†’ automaticky pÅ™idÃ¡ VZP status
3. PorovnÃ¡vÃ¡ lÃ©ky: *"Empagliflozin vs dapagliflozin"* â†’ pro oba zobrazÃ­ VZP data
4. Follow-up na pÅ™edchozÃ­ odpovÄ›Ä: *"A kolik to stojÃ­ pacienta?"*

### Kde se VZP Data ZobrazujÃ­

VZP informace se vykreslujÃ­ **uvnitÅ™ Benjamin Response Bubble** jako strukturovanÃ¡ sekce mezi hlavnÃ­m textem odpovÄ›di a Sources Panel.

---

## Visual Design - VZP Info Card

### Layout Structure

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Benjamin Response (Main Text)                                â”‚
â”‚                                                               â”‚
â”‚ Empagliflozin (Jardiance) je SGLT2 inhibitor doporuÄenÃ½     â”‚
â”‚ pro pacienty s T2DM a vysokÃ½m kardiovaskulÃ¡rnÃ­m rizikem...  â”‚
â”‚                                                               â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚ â”‚ ğŸ’Š VZP ÃšHRADOVÃ‰ INFORMACE                              â”‚   â”‚
â”‚ â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚   â”‚
â”‚ â”‚                                                         â”‚   â”‚
â”‚ â”‚ ğŸ“¦ Empagliflozin (Jardiance 10mg, 25mg)               â”‚   â”‚
â”‚ â”‚                                                         â”‚   â”‚
â”‚ â”‚ âœ… HRAZENÃ                                              â”‚   â”‚
â”‚ â”‚ â€¢ StandardnÃ­ Ãºhrada VZP                                â”‚   â”‚
â”‚ â”‚ â€¢ Indikace: Diabetes mellitus 2. typu (E11)           â”‚   â”‚
â”‚ â”‚ â€¢ PodmÃ­nky: HbA1c â‰¥ 53 mmol/mol po selhÃ¡nÃ­ metforminuâ”‚   â”‚
â”‚ â”‚                                                         â”‚   â”‚
â”‚ â”‚ ğŸ’° DOPLATEK PACIENTA                                   â”‚   â”‚
â”‚ â”‚ â€¢ 30 KÄ (recept s plnou Ãºhradou)                      â”‚   â”‚
â”‚ â”‚                                                         â”‚   â”‚
â”‚ â”‚ ğŸ“‹ KÃ“DY PRO PÅ˜EDPIS                                    â”‚   â”‚
â”‚ â”‚ â€¢ KÃ³d omezenÃ­: H013 (Endokrinologie/InternÃ­)          â”‚   â”‚
â”‚ â”‚ â€¢ ICD-10 diagnÃ³za: E11 (Diabetes mellitus 2. typu)    â”‚   â”‚
â”‚ â”‚                                                         â”‚   â”‚
â”‚ â”‚ âš ï¸ UPOZORNÄšNÃ                                           â”‚   â”‚
â”‚ â”‚ â€¢ Pokud HbA1c < 53 â†’ Å¾Ã¡dost o IU nutnÃ¡                â”‚   â”‚
â”‚ â”‚   [ğŸ“„ Jak podat Å¾Ã¡dost o IU]                          â”‚   â”‚
â”‚ â”‚                                                         â”‚   â”‚
â”‚ â”‚ ğŸ”„ Aktualizace: 15.1.2025 | ğŸ”— VZP Seznam LP          â”‚   â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                               â”‚
â”‚ ğŸ“š Zobrazit 3 zdroje (PubMed, SÃšKL, ÄŒLS JEP)                â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Component Breakdown

#### 1. Header Section
- **Icon + Label:** `ğŸ’Š VZP ÃšHRADOVÃ‰ INFORMACE`
- **Visual Style:**
  - Light purple/blue background `rgba(139, 92, 246, 0.08)`
  - Border: `1px solid rgba(139, 92, 246, 0.2)`
  - Border radius: `12px`
  - Padding: `16px`
  - Font: Inter Medium, 14px

#### 2. Drug Name
- **Text:** `ğŸ“¦ Empagliflozin (Jardiance 10mg, 25mg)`
- **Style:** Semi-bold, 15px, dark gray `#1F2937`

#### 3. HrazenÃ­ Status (Primary Info)
**Green Indicator pro hrazenÃ© lÃ©ky:**
```
âœ… HRAZENÃ
â€¢ StandardnÃ­ Ãºhrada VZP
â€¢ Indikace: Diabetes mellitus 2. typu (E11)
â€¢ PodmÃ­nky: HbA1c â‰¥ 53 mmol/mol po selhÃ¡nÃ­ metforminu
```

**Red Indicator pro nehrazenÃ©:**
```
âŒ NENÃ HRAZENO
â€¢ LÃ©k nenÃ­ na Seznamu kategorizovanÃ½ch LP
â€¢ Ãšhrada: Pacient platÃ­ plnou cenu (~1,200 KÄ/mÄ›sÃ­c)
â€¢ MoÅ¾nost: Å½Ã¡dost o individuÃ¡lnÃ­ Ãºhradu (IU)
  [ğŸ“„ Jak podat Å¾Ã¡dost o IU]
```

**Yellow Indicator pro ÄÃ¡steÄnÃ© hrazenÃ­:**
```
âš ï¸ ÄŒÃSTEÄŒNÃ‰ HRAZENÃ
â€¢ LÃ©k hrazen pouze pro specifickÃ© indikace
â€¢ VaÅ¡e indikace: SrdeÄnÃ­ selhÃ¡nÃ­ (off-label)
â€¢ Å½Ã¡dost o IU nutnÃ¡
  [ğŸ“„ Template Å¾Ã¡dosti o IU]
```

#### 4. Doplatek Pacienta
- **Icon:** `ğŸ’° DOPLATEK PACIENTA`
- **Content:**
  - `30 KÄ (recept s plnou Ãºhradou)`
  - nebo: `50 KÄ (50% Ãºhrada)` nebo `350 KÄ (pacient doplÃ¡cÃ­ rozdÃ­l)`

#### 5. KÃ³dy pro PÅ™edpis (Prescribing Codes)
- **Icon:** `ğŸ“‹ KÃ“DY PRO PÅ˜EDPIS`
- **Content:**
  - `KÃ³d omezenÃ­: H013 (Endokrinologie/Internista)`
  - `ICD-10 diagnÃ³za: E11 (Diabetes mellitus 2. typu)`
- **Purpose:** KopÃ­rovatelnÃ© kÃ³dy pro e-recept systÃ©m

#### 6. UpozornÄ›nÃ­ (Warnings/Special Conditions)
- **Icon:** `âš ï¸ UPOZORNÄšNÃ`
- **Use Cases:**
  - Off-label pouÅ¾itÃ­
  - DodateÄnÃ© podmÃ­nky (lab hodnoty, pÅ™edchozÃ­ terapie)
  - Link na Å¾Ã¡dost o IU

#### 7. Footer (Data Freshness)
- **Text:** `ğŸ”„ Aktualizace: 15.1.2025 | ğŸ”— VZP Seznam LP`
- **Style:** Small gray text, 12px, clickable link k VZP zdroji

---

## Interactive States

### 1. Collapsed State (Default)
KdyÅ¾ Benjamin zmÃ­nÃ­ lÃ©k v odpovÄ›di, zobrazÃ­ se kompaktnÃ­ badge:

```
ğŸ’Š Empagliflozin â€¢ âœ… Hrazeno VZP (30 KÄ) [Zobrazit detaily â–¼]
```

**Click action:** Expanduje na plnou VZP Info Card

### 2. Expanded State
PlnÃ¡ VZP Info Card s vÅ¡emi sekcemi (viz Layout Structure vÃ½Å¡e)

### 3. Multiple Drugs Comparison
Pokud lÃ©kaÅ™ porovnÃ¡vÃ¡ 2+ lÃ©ky, zobrazit VZP data side-by-side:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š Empagliflozin         â”‚ ğŸ’Š Dapagliflozin         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ âœ… Hrazeno               â”‚ âœ… Hrazeno               â”‚
â”‚ Doplatek: 30 KÄ          â”‚ Doplatek: 50 KÄ          â”‚
â”‚ KÃ³d: H013                â”‚ KÃ³d: H013                â”‚
â”‚                          â”‚                          â”‚
â”‚ [Detail â–¼]              â”‚ [Detail â–¼]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

ğŸ’¡ Empagliflozin je levnÄ›jÅ¡Ã­ pro pacienta (20 KÄ rozdÃ­l/mÄ›sÃ­c)
```

### 4. Loading State
BÄ›hem fetchovÃ¡nÃ­ VZP dat (1-2 sekundy):

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š VZP ÃšHRADOVÃ‰ INFORMACE               â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                          â”‚
â”‚ â³ Kontroluji VZP databÃ¡zi...           â”‚
â”‚ [Animated spinner]                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 5. Error State
Pokud VZP data nejsou dostupnÃ¡:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š VZP ÃšHRADOVÃ‰ INFORMACE               â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                          â”‚
â”‚ âš ï¸ VZP data doÄasnÄ› nedostupnÃ¡          â”‚
â”‚                                          â”‚
â”‚ [ğŸ”„ Zkusit znovu] [ğŸ”— OtevÅ™Ã­t VZP web] â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Follow-up Actions (Interactive Buttons)

Pod VZP Info Card zobrazit **akÄnÃ­ tlaÄÃ­tka** pro rychlÃ© follow-up:

```
[ğŸ“„ Jak podat Å¾Ã¡dost o IU] [ğŸ’° Srovnat ceny alternativ] [ğŸ“‹ KopÃ­rovat kÃ³dy]
```

### Button Actions

#### 1. "Jak podat Å¾Ã¡dost o IU"
**Trigger:** Click opens expandable section s step-by-step guide:

```
ğŸ“„ Å½ÃDOST O INDIVIDUÃLNÃ ÃšHRADU (IU)

1. FormulÃ¡Å™:
   â€¢ VZP Å½Ã¡dost o individuÃ¡lnÃ­ Ãºhradu (FormulÃ¡Å™ Ä. 12345)
   â€¢ Ke staÅ¾enÃ­: [ğŸ”— VZP web]

2. PotÅ™ebnÃ¡ dokumentace:
   â€¢ LÃ©kaÅ™skÃ¡ zprÃ¡va s odÅ¯vodnÄ›nÃ­m
   â€¢ Dokumentace o selhÃ¡nÃ­ standardnÃ­ terapie
   â€¢ Literatura podporujÃ­cÃ­ off-label pouÅ¾itÃ­

3. DoporuÄenÃ© odÅ¯vodnÄ›nÃ­:
   "Pacient s T2DM a NYHA II srdeÄnÃ­m selhÃ¡nÃ­m, kde empagliflozin
    prokÃ¡zal kardiorenal benefit (EMPA-REG OUTCOME, DAPA-HF studie).
    Metformin kontraindikovÃ¡n kvÅ¯li GFR 25 ml/min."

4. ÄŒekacÃ­ doba:
   â€¢ StandardnÃ­: 30 dnÅ¯
   â€¢ UrgentnÃ­: 7 dnÅ¯ (pÅ™i akutnÃ­ indikaci)

[ğŸ“‹ Vygenerovat template Å¾Ã¡dosti pro tohoto pacienta]
```

#### 2. "Srovnat ceny alternativ"
**Trigger:** Opens price comparison table:

```
ğŸ’° CENOVÃ‰ SROVNÃNÃ - SGLT2 INHIBITORY

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ LÃ©k          â”‚ Doplatek â”‚ MÄ›sÃ­ÄnÃ­   â”‚ HrazenÃ­    â”‚
â”‚              â”‚ pacienta â”‚ nÃ¡klady   â”‚ VZP        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Empagliflozinâ”‚ 30 KÄ    â”‚ 850 KÄ    â”‚ âœ… Ano     â”‚
â”‚ Dapagliflozinâ”‚ 50 KÄ    â”‚ 920 KÄ    â”‚ âœ… Ano     â”‚
â”‚ Canagliflozinâ”‚ 45 KÄ    â”‚ 890 KÄ    â”‚ âœ… Ano     â”‚
â”‚ Ertugliflozinâ”‚ 120 KÄ   â”‚ 1,200 KÄ  â”‚ âš ï¸ Omezeno â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

ğŸ’¡ DoporuÄenÃ­: Empagliflozin - nejniÅ¾Å¡Ã­ doplatek + prokÃ¡zanÃ½ CV benefit
```

#### 3. "KopÃ­rovat kÃ³dy"
**Trigger:** KopÃ­ruje prescribing codes do clipboardu:

```
âœ… ZkopÃ­rovÃ¡no do schrÃ¡nky:

KÃ³d omezenÃ­: H013
ICD-10: E11
SÃšKL kÃ³d: 0123456
DÃ¡vkovÃ¡nÃ­: 10mg 1x dennÄ›
```

---

## Advanced Use Cases

### Scenario A: Off-label Prescribing

**User Query:** *"Je empagliflozin hrazenÃ½ pro srdeÄnÃ­ selhÃ¡nÃ­?"*

**Benjamin Response with VZP Data:**

```
Empagliflozin (Jardiance) prokÃ¡zal benefit u pacientÅ¯ se srdeÄnÃ­m
selhÃ¡nÃ­m ve studiÃ­ch EMPEROR-Reduced a EMPEROR-Preserved [1][2].

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š VZP ÃšHRADOVÃ‰ INFORMACE                                    â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                               â”‚
â”‚ âš ï¸ OFF-LABEL POUÅ½ITÃ                                          â”‚
â”‚                                                               â”‚
â”‚ â€¢ Indikace: SrdeÄnÃ­ selhÃ¡nÃ­ (I50.x)                         â”‚
â”‚ â€¢ VZP hrazenÃ­: âŒ NE (registrovÃ¡n pouze pro T2DM)           â”‚
â”‚ â€¢ Doplatek pacienta: ~1,200 KÄ/mÄ›sÃ­c (plnÃ¡ cena)            â”‚
â”‚                                                               â”‚
â”‚ ğŸ’¡ MOÅ½NOSTI:                                                  â”‚
â”‚ â€¢ Å½Ã¡dost o individuÃ¡lnÃ­ Ãºhradu (IU)                          â”‚
â”‚   â†’ Evidence: EMPEROR-Reduced (2020), ESC guidelines 2021    â”‚
â”‚   â†’ Success rate: ~60% (high evidence base)                  â”‚
â”‚                                                               â”‚
â”‚ â€¢ Alternativa: Dapagliflozin (Forxiga)                       â”‚
â”‚   â†’ âœ… Hrazeno VZP pro srdeÄnÃ­ selhÃ¡nÃ­ od 2023              â”‚
â”‚   â†’ Doplatek: 50 KÄ                                          â”‚
â”‚                                                               â”‚
â”‚ [ğŸ“„ Vygenerovat Å¾Ã¡dost o IU] [ğŸ”„ PouÅ¾Ã­t dapagliflozin]      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Scenario B: Price Comparison with Generic

**User Query:** *"JakÃ½ je nejlevnÄ›jÅ¡Ã­ ACE inhibitor pro pacienta?"*

**Benjamin Response:**

```
Pro pacienty s hypertenzÃ­ nebo po infarktu myokardu jsou ACE inhibitory
prvnÃ­ volbou. NejlevnÄ›jÅ¡Ã­ opcÃ­ jsou generika ramipril nebo perindopril.

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š VZP CENOVÃ‰ SROVNÃNÃ - ACE INHIBITORY                      â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                               â”‚
â”‚ ğŸ’° NEJLEVNÄšJÅ Ã PRO PACIENTA:                                 â”‚
â”‚                                                               â”‚
â”‚ 1. Ramipril (generikum)                                      â”‚
â”‚    â€¢ Doplatek: 15 KÄ/mÄ›sÃ­c                                   â”‚
â”‚    â€¢ DÃ¡vkovÃ¡nÃ­: 5mg 1x dennÄ›                                 â”‚
â”‚    â€¢ KÃ³d: C09AA (bez omezenÃ­)                                â”‚
â”‚                                                               â”‚
â”‚ 2. Perindopril (generikum)                                   â”‚
â”‚    â€¢ Doplatek: 20 KÄ/mÄ›sÃ­c                                   â”‚
â”‚    â€¢ DÃ¡vkovÃ¡nÃ­: 5mg 1x dennÄ›                                 â”‚
â”‚                                                               â”‚
â”‚ 3. Enalapril (generikum)                                     â”‚
â”‚    â€¢ Doplatek: 18 KÄ/mÄ›sÃ­c                                   â”‚
â”‚    â€¢ DÃ¡vkovÃ¡nÃ­: 10mg 2x dennÄ› (âš ï¸ 2x dennÄ› compliance)      â”‚
â”‚                                                               â”‚
â”‚ âš ï¸ ORIGINÃLY (DRAÅ½Å Ã):                                        â”‚
â”‚ â€¢ Tritace (ramipril): 85 KÄ/mÄ›sÃ­c (+70 KÄ vs generikum)     â”‚
â”‚ â€¢ Prestarium (perindopril): 95 KÄ/mÄ›sÃ­c                      â”‚
â”‚                                                               â”‚
â”‚ ğŸ’¡ DoporuÄenÃ­: Ramipril generikum - nejniÅ¾Å¡Ã­ cena + 1x dennÄ›â”‚
â”‚                                                               â”‚
â”‚ [ğŸ“‹ PÅ™edepsat ramipril 5mg] [ğŸ’° Detail vÅ¡ech ACE inhibitorÅ¯]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Scenario C: Drug Not Registered in Czech Republic

**User Query:** *"Je tirzepatide hrazenÃ½ v ÄŒR?"*

**Benjamin Response:**

```
Tirzepatide (Mounjaro) je duÃ¡lnÃ­ GIP/GLP-1 agonista s vÃ½raznÃ½m efektem
na glykemickou kontrolu a hmotnost [1].

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š VZP ÃšHRADOVÃ‰ INFORMACE                                    â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                               â”‚
â”‚ âŒ NENÃ REGISTROVÃN V ÄŒR                                      â”‚
â”‚                                                               â”‚
â”‚ â€¢ SÃšKL registrace: âŒ NE (k 15.1.2025)                       â”‚
â”‚ â€¢ EMA approval: âœ… ANO (2022)                                â”‚
â”‚ â€¢ OÄekÃ¡vanÃ¡ registrace ÄŒR: Q3 2025 (pÅ™edbÄ›Å¾nÃ©)              â”‚
â”‚                                                               â”‚
â”‚ ğŸ’¡ AKTUÃLNÃ SITUACE:                                          â”‚
â”‚ â€¢ LÃ©k nenÃ­ dostupnÃ½ v ÄeskÃ½ch lÃ©kÃ¡rnÃ¡ch                      â”‚
â”‚ â€¢ Import ze zahraniÄÃ­: MoÅ¾nÃ½, ale bez VZP Ãºhrady            â”‚
â”‚ â€¢ NÃ¡klady: ~8,000 KÄ/mÄ›sÃ­c (pacient platÃ­ vÅ¡e)              â”‚
â”‚                                                               â”‚
â”‚ ğŸ”„ HRAZENÃ‰ ALTERNATIVY:                                       â”‚
â”‚ â€¢ Semaglutide (Ozempic) - âœ… Hrazeno VZP                     â”‚
â”‚   Doplatek: 150 KÄ, podobnÃ½ efekt (GLP-1 agonista)          â”‚
â”‚ â€¢ Dulaglutide (Trulicity) - âœ… Hrazeno VZP                   â”‚
â”‚   Doplatek: 120 KÄ, 1x tÃ½dnÄ› aplikace                        â”‚
â”‚                                                               â”‚
â”‚ [ğŸ“‹ Detail semaglutide] [ğŸ”” Upozornit na registraci]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Suggested Follow-ups (Conversational AI)

Po zobrazenÃ­ VZP Info Card AI automaticky navrhne follow-up otÃ¡zky:

```
ğŸ¤” MoÅ¾nÃ¡ vÃ¡s zajÃ­mÃ¡:
â€¢ JakÃ© jsou podmÃ­nky pro pÅ™edpis empagliflozinu?
â€¢ JakÃ© alternativy jsou hrazenÃ©?
â€¢ Jak napsat Å¾Ã¡dost o individuÃ¡lnÃ­ Ãºhradu?
```

---

## ResponzivnÃ­ Layout

### Desktop Modal (1200Ã—800px)
- VZP Info Card: Full width (90% of chat area)
- Side-by-side comparison: 2 columns

### Chrome Extension (800Ã—600px)
- VZP Info Card: Full width (95% of chat area)
- Comparison mode: Stacked vertically (scrollable)

### Mobile/Tablet (400Ã—600px)
- VZP Info Card: Full width
- Collapsed by default (pouze badge)
- Comparison: Vertical tabs (swipeable)

---

## Edge Cases & Error Handling

### Case 1: VZP Data StarÃ¡ (>3 mÄ›sÃ­ce)
```
âš ï¸ UpozornÄ›nÃ­: Data VZP starÅ¡Ã­ neÅ¾ 90 dnÃ­ (poslednÃ­ aktualizace: 15.10.2024)
DoporuÄujeme ovÄ›Å™it aktuÃ¡lnÃ­ status na VZP web.
[ğŸ”— OtevÅ™Ã­t VZP Seznam LP]
```

### Case 2: LÃ©k MÃ¡ VÃ­ce IndikacÃ­ s RÅ¯znÃ½m HrazenÃ­m
```
âš ï¸ HRAZENÃ ZÃVISÃ NA INDIKACI

â€¢ Diabetes 2. typu (E11): âœ… Hrazeno (30 KÄ doplatek)
â€¢ SrdeÄnÃ­ selhÃ¡nÃ­ (I50): âŒ NenÃ­ hrazeno (Å¾Ã¡dost o IU)
â€¢ ChronickÃ© onemocnÄ›nÃ­ ledvin: âœ… Hrazeno od 2024

ğŸ’¡ Vyberte indikaci pro detail hrazenÃ­:
[E11 Diabetes] [I50 SrdeÄnÃ­ selhÃ¡nÃ­] [N18 CKD]
```

### Case 3: VZP API NedostupnÃ©
```
âš ï¸ VZP databÃ¡ze doÄasnÄ› nedostupnÃ¡

Zobrazuji cached data (aktualizace: 10.1.2025).
Pro nejnovÄ›jÅ¡Ã­ informace navÅ¡tivte VZP web.

[ğŸ”„ Zkusit znovu] [ğŸ”— VZP web]
```

---

## Accessibility

- **ARIA Labels:** `aria-label="VZP ÃºhradovÃ© informace pro empagliflozin"`
- **Keyboard Navigation:**
  - `Tab` pro pÅ™esun mezi sekcemi
  - `Enter` pro expand/collapse
  - `Cmd+C` pro kopÃ­rovÃ¡nÃ­ kÃ³dÅ¯
- **Screen Reader:** Announce VZP status pÅ™i zobrazenÃ­ card
- **High Contrast Mode:** Green/Red status indicators majÃ­ ikony (âœ…/âŒ)

---

## Performance Optimizations

- **Pre-fetching:** Pokud AI detekuje zmÃ­nku o lÃ©ku, zaÄne fetchovat VZP data paralelnÄ› bÄ›hem generovÃ¡nÃ­ odpovÄ›di
- **Caching:** VZP data pro populÃ¡rnÃ­ lÃ©ky (top 100) cached in Supabase (TTL 30 dnÃ­)
- **Lazy Load:** VZP Info Card se renderuje aÅ¾ po dokonÄenÃ­ main response text (ne bÄ›hem streamingu)

---

## Success Metrics (KPIs)

- **Adoption:** 70% lÃ©kaÅ™Å¯ pouÅ¾Ã­vÃ¡ VZP Navigator â‰¥5x tÃ½dnÄ›
- **Time Savings:** 5 min (manuÃ¡lnÃ­ VZP kontrola) â†’ 0 min = 100% Ãºspora
- **Accuracy:** 95%+ pÅ™esnost VZP dat vs oficiÃ¡lnÃ­ VZP web
- **User Satisfaction:** "Pomohlo mi VZP Navigator?" â†’ 85%+ ANO
- **Conversion:** 20% lÃ©kaÅ™Å¯ upgraduje na Pro plan kvÅ¯li VZP Navigator

---

## Technical Notes (pro Backend)

### MCP Tool: VZP Navigator

**Input:**
```json
{
  "drug_name": "empagliflozin",
  "indication": "E11", // Optional ICD-10 code
  "patient_context": { // Optional
    "age": 65,
    "insurance": "VZP" // Future: other insurers
  }
}
```

**Output:**
```json
{
  "reimbursement_status": "reimbursed",
  "copay_czk": 30,
  "restriction_code": "H013",
  "indications": ["E11"],
  "conditions": "HbA1c â‰¥ 53 mmol/mol po selhÃ¡nÃ­ metforminu",
  "off_label_note": null,
  "last_updated": "2025-01-15",
  "source_url": "https://www.vzp.cz/..."
}
```

### Database Schema (Supabase)
```sql
CREATE TABLE vzp_reimbursement (
  id UUID PRIMARY KEY,
  drug_name TEXT NOT NULL,
  atc_code TEXT,
  reimbursement_status TEXT, -- 'reimbursed', 'not_reimbursed', 'conditional'
  copay_czk INTEGER,
  restriction_code TEXT,
  indication_icd10 TEXT[],
  conditions TEXT,
  last_updated TIMESTAMP,
  source_url TEXT,
  created_at TIMESTAMP DEFAULT NOW()
);
```

---

## ZÃ¡vÄ›r

VZP Navigator je **high-impact, low-friction feature**, kterÃ¡ poskytuje unikÃ¡tnÃ­ competitive advantage (Å¾Ã¡dnÃ½ konkurent nemÃ¡ VZP data). Implementuje se jako inline enhancement existujÃ­cÃ­ho Chat UI, takÅ¾e nevyÅ¾aduje novÃ© obrazovky nebo UX flows â€” pouze obohacenÃ­ stÃ¡vajÃ­cÃ­ch odpovÄ›dÃ­ o strukturovanÃ¡ VZP data.
